11th-Hour Deal Lets Pfizer Exit As Cancer Patent Trial Begins
Pfizer Inc. and Bristol-Myers Squibb Co. reached a settlement on the eve of a trial in Boston on Monday in which Dana-Farber Cancer Institute is seeking to add two American researchers...To view the full article, register now.
Already a subscriber? Click here to view full article